NCT00019916View on ClinicalTrials.gov

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Study Completion Date

July 31, 2006

Conditions
Breast CancerOvarian Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

p53 peptide vaccine

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (2)

20889

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019916 - Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | Biotech Hunter | Biotech Hunter